Xiao Hu

Papers

Total Citations

H-Index

About

Xiao Hu is a pioneering researcher at the intersection of artificial intelligence and aging biology, whose work is redefining how we discover longevity therapeutics. Their most notable contribution comes from a landmark 2024 study demonstrating how an AI-driven robotics laboratory identified pharmacological TNIK inhibition as a potent senomorphic agent—a compound that suppresses the harmful effects of cellular senescence without killing senescent cells. This breakthrough, already garnering 11 citations in under a year, showcases Hu’s innovative approach to targeting aging hallmarks by simultaneously prioritizing dual-purpose therapeutic targets and developing drugs that combat both aging and disease. By leveraging machine learning to accelerate drug discovery, Hu has opened new avenues for treating age-related pathologies, positioning their work at the forefront of geroscience. Their research not only advances our understanding of cellular senescence as a central aging hallmark but also provides a scalable, AI-powered framework for identifying next-generation senotherapeutics. For students and researchers, Hu’s work exemplifies how computational biology and automated experimentation can transform longevity research from descriptive to interventional, offering a glimpse into the future of precision anti-aging medicine.